These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 37881313)
1. Significant potential of melatonin therapy in Parkinson's disease - a meta-analysis of randomized controlled trials. Iftikhar S; Sameer HM; Zainab Front Neurol; 2023; 14():1265789. PubMed ID: 37881313 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of hyperbaric oxygen therapy as an adjunct therapy in the treatment of sleep disorders among patients with Parkinson's disease: a meta-analysis. Tan WQ; Liu Q; Cen MJ; Leong II; Pan ZQ; Liao MX; Zhuang LX Front Neurol; 2024; 15():1328911. PubMed ID: 39144713 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Aboulatta L; Haidar L; Abou-Setta A; Askin N; Rabbani R; Lavu A; Peymani P; Zarychanski R; Eltonsy S CNS Drugs; 2023 Nov; 37(11):941-956. PubMed ID: 37973769 [TBL] [Abstract][Full Text] [Related]
5. Melatonin Treatment for Sleep Disorders in Parkinson's Disease: A Meta-Analysis and Systematic Review. Ma H; Yan J; Sun W; Jiang M; Zhang Y Front Aging Neurosci; 2022; 14():784314. PubMed ID: 35185525 [TBL] [Abstract][Full Text] [Related]
6. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial. Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307 [TBL] [Abstract][Full Text] [Related]
7. Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials. Zhang W; Chen XY; Su SW; Jia QZ; Ding T; Zhu ZN; Zhang T Neurol Sci; 2016 Jan; 37(1):57-65. PubMed ID: 26255301 [TBL] [Abstract][Full Text] [Related]
8. Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease. Elsner B; Kugler J; Pohl M; Mehrholz J Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010916. PubMed ID: 27425786 [TBL] [Abstract][Full Text] [Related]
9. Overall Efficacy and Safety of Safinamide in Parkinson's Disease: A Systematic Review and a Meta-analysis. Giossi R; Carrara F; Mazzari M; Lo Re F; Senatore M; Schicchi A; Corrù F; Fittipaldo VA; Pani A; Tramacere I; Elia AE; Scaglione F Clin Drug Investig; 2021 Apr; 41(4):321-339. PubMed ID: 33674954 [TBL] [Abstract][Full Text] [Related]
10. Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson's disease: a preliminary evidence. Liguori C; Fernandes M; Cerroni R; Ludovisi R; Mercuri NB; Stefani A; Pierantozzi M Neurol Sci; 2022 Sep; 43(9):5355-5362. PubMed ID: 35536495 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapies for sleep disturbances in dementia. McCleery J; Sharpley AL Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083 [TBL] [Abstract][Full Text] [Related]
12. The effects of bright light therapy on depression and sleep disturbances in patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. Lin F; Su Y; Weng Y; Lin X; Weng H; Cai G; Cai G Sleep Med; 2021 Jul; 83():280-289. PubMed ID: 34052783 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Rotigotine Transdermal Patch on Neuropsychiatric Symptoms of Parkinson's Disease: An Updated Meta-Analysis and Systematic Review. Yan J; Ma H; Liu A; Huang J; Wu J; Yang J Front Neurol; 2021; 12():722892. PubMed ID: 34744967 [No Abstract] [Full Text] [Related]
14. Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial. Hadi F; Agah E; Tavanbakhsh S; Mirsepassi Z; Mousavi SV; Talachi N; Tafakhori A; Aghamollaii V Neurol Sci; 2022 Oct; 43(10):6141-6148. PubMed ID: 35660990 [TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of safety and efficacy of safinamide for motor fluctuations in patients with Parkinson's disease. Abdelalem Aziz Ahmed M F1000Res; 2019; 8():2078. PubMed ID: 32431802 [No Abstract] [Full Text] [Related]
16. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. Medeiros CA; Carvalhedo de Bruin PF; Lopes LA; Magalhães MC; de Lourdes Seabra M; de Bruin VM J Neurol; 2007 Apr; 254(4):459-64. PubMed ID: 17404779 [TBL] [Abstract][Full Text] [Related]
17. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Ernst M; Folkerts AK; Gollan R; Lieker E; Caro-Valenzuela J; Adams A; Cryns N; Monsef I; Dresen A; Roheger M; Eggers C; Skoetz N; Kalbe E Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013856. PubMed ID: 36602886 [TBL] [Abstract][Full Text] [Related]
18. Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials. Shan CS; Zhang HF; Xu QQ; Shi YH; Wang Y; Li Y; Lin Y; Zheng GQ Front Aging Neurosci; 2018; 10():349. PubMed ID: 30467472 [No Abstract] [Full Text] [Related]
19. Effectiveness of therapeutic massage for improving motor symptoms in Parkinson's disease: A systematic review and meta-analysis. Kang Z; Xing H; Lin Q; Meng F; Gong L Front Neurol; 2022; 13():915232. PubMed ID: 36133798 [TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapies for sleep disturbances in Alzheimer's disease. McCleery J; Cohen DA; Sharpley AL Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]